Andere Sprachen Bora Pharmaceuticals Co., LTD.

Aktien

6472

TW0006472004

6472

Pharmazeutika

Schlusskurs Taiwan S.E. Andere Börsenplätze 16.12.2025			% 5 Tage	Veränd. 1. Jan.
498,50 ^TWD	-0,89 %		-2,64 %	-20,47 %

16.12.	Bora Pharmaceuticals Co., LTD., Q3 2025 Earnings Call, Nov 13, 2025
09.12.	Bora Pharmaceuticals und Corealis Pharma schließen strategische Allianz für nahtlose Entwicklung von oralen Festdosen	CI

Andere Sprachen

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-To-End Oral Solid Dose Development	09.12.
Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development	09.12.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	13.11.
Bora Pharmaceuticals says Jan-Sept net profit T$2.65 bln	13.11.
Bora Pharmaceuticals to Issue Level 1 ADRs in US OTC Market	13.10.
Bora Pharmaceuticals plans to sell up to 12.44 million shares on US market	13.10.
ProMed Pharma, LLC acquired 28,000 square foot, state-of-the-art pharmaceutical manufacturing facility in Plymouth, Minnesota from Bora Pharmaceuticals Co., LTD..	19.08.
Bora Pharmaceuticals says Jan-Jun net profit T$2.02 bln	08.08.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	07.08.
Bora Pharmaceuticals Co., Ltd. Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Splitis Finalized	06.08.
Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Finalized	05.08.
Bora Pharmaceuticals Cuts Stock Dividend Rate	18.07.
Tranche Update on Bora Pharmaceuticals Co., LTD.'s Equity Buyback Plan announced on April 8, 2025.	06.06.
Bora Pharmaceuticals Co., LTD. Announces Cash Dividend, Payable on July 11, 2025	23.05.
Tanvex BioPharma, Inc. announced that it expects to receive TWD 400 million in funding from Bora Pharmaceuticals Co., LTD.	23.05.
Bora Pharmaceuticals Logs NT$1.4 Billion Profit in Q1	14.05.
Bora Pharmaceuticals Says Q1 Net Profit T$1.4 Bln	14.05.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2025	13.05.
Bora Pharmaceuticals Co., LTD.'s Equity Buyback announced on April 8, 2025, has expired with 36,000 shares, representing 0.03% for TWD 23.71 million.	24.04.
Bora Pharmaceuticals Co., LTD. announces an Equity Buyback for 500,000 shares, representing 0.48% for TWD 9,860.53 million.	08.04.
Bora Pharmaceuticals Co., LTD. authorizes a Buyback Plan.	08.04.
Tanvex BioPharma Elects Chairman	28.03.
Bora Pharmaceuticals Says 2024 Full-Year Net Profit T$3.94 Bln	05.03.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2024	05.03.
Bora Pharmaceuticals Co., Ltd. Announces Dividend for Second Half Ended December 31, 2024	05.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bora Pharmaceuticals Co., LTD.

Aktien

6472

TW0006472004

6472

Pharmazeutika

Andere Sprachen

Filter